Factors affecting survival in juvenile systemic sclerosis

Rheumatology

Volumn 48, Issue 2, 2009, Pages 119-122

  Martini, G ^a   Vittadello, F ^a   Kasapcopur O ^b   Magni Manzoni, S ^c   Corona, F ^d   Duarte Salazar, C ^e   Nemcova, D ^f   Len, C A ^g   Garay, S M ^h   Ullman, S ⁱ   Zulian, F ^a   Cuttica, Ruben ^j   Russo, Ricardo ^j   Espada, Graciela ^j   Apaz, María Teresa ^j   Hilario, Maria Odete ^j   Lotito, Ana Paola ^j   Machado, Claudia ^j   Sztajnbok, Flavio ^j   De Oliveira, Sheila Knupp F ^j   Liphaus, Bernadete de I ^j   Almeida da Silva, Clovis A ^j   Saurenmann, Traudel ^j   Nielsen, Susan ^j   Cate, Rebecca Ten ^j   Van Suijlekom Smit, Lisette ^j   Girschick, Hermann ^j   Foeldvari, Ivan ^j   Horneff, Gerd ^j   Wouters, Carine ^j   Galea, Paul ^j   Woo, Patricia ^j   Merino, Rosa ^j   Roldan Molina, Rosa ^j   Gàmir, Maria Luz ^j   Ros, Joan ^j   Fischbach, Michel ^j   Ravelli, Angelo ^j   Buoncompagni, Antonella ^j   Cortis, Elisabetta ^j   Falcini, Fernanda ^j   Alpigiani, Maria Giannina ^j   Ferri, Clodoveo ^j   Scegolev, Andrey ^j   Němcová, Dana ^j   Orbàn, Ilonka ^j   Zielińska, Henryka Mazur ^j   Musiej Nowakowska, Elzbieta ^j   Avcin, Tadej ^j   Srdjan, Pasic ^j   Stojanovic, Roksanda ^j   Susic, Gordana ^j   Masha, Mukamel ^j   Uziel, Yoseph ^j   Lyskina, Galina A ^j   Al Mayouf, Sulaiman ^j   Eberhard, Anne ^j   Higgins, Gloria ^j   Punaro, Lynn ^j   Nelson, Audrey ^j   Sundel, Robert ^j   Moore, Terry L ^j   Athreya, Balu H ^j   Lehman, Thomas ^j   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b ISTANBUL UNIVERSITY   (Turkey)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d Clinica Pediatrica De Marchi   (Italy)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^f CHARLES UNIVERSITY   (Czech Republic)

^g FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^h Hospital de Ninos Sor Maria Ludovica   (Argentina)

ⁱ University Hospitals ^*  (Denmark)

^j NONE

more..

Author keywords

Child; Mortality; Outcome; Scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CREATININE; DOUBLE STRANDED DNA ANTIBODY; SCL 70 ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; IMMUNE RESPONSE; INFANT; LABORATORY TEST; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MUSCULOSKELETAL DISEASE; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PERICARDITIS; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; SURVIVAL RATE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; VASCULAR DISEASE;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CHILD; EUROPE; FOLLOW-UP STUDIES; HUMANS; MULTIVARIATE ANALYSIS; NORTH AMERICA; PERICARDITIS; PROGNOSIS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SOUTH AMERICA; SURVIVAL;

EID: 58749089682     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken388     Document Type: Article

References (14)

1. Martini G, Foeldvari I, Russo R et al. Systemic sclerosis in childhood: Clinical and immunological features of 153 patients. An international database. Arthritis Rheum 2006;54:3971-8.
2. Scalapino K, Arkachaisri T, Lucas M et al. Childhood onset systemic sclerosis: Classification, clinical and serologic features and survival in comparison with adult onset disease. J Rheumatol 2006;33:1004-13.
3. Suárez-Almazor ME, Catoggio LJ, Maldonado-Cocco JA, Cuttica R, García-Morteo O. Juvenile progressive systemic sclerosis: Clinical and serologic findings. Arthritis Rheum 1985;28:699-702.
4. Lababidi HMS, Nasr FW, Khatib Z. Juvenile progressive systemic sclerosis: Report of five cases. J Rheumatol 1991;18:885-8.
5. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
6. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis. J Rheumatol 1988;15:202-5.
7. Scussel-Lonzetti L, Joyal F, Raynauld JP et al. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 2002;81: 154-67.
8. Lee P, Langevitz P, Alderdice CA et al. Mortality in systemic sclerosis (scleroderma). Q J Med 1992;82:139-48.
9. Altman RD, Medsger TA Jr, Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
10. Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 2001;28:2454-59.
11. Ferri C, Valentini G, Cozzi F et al. Systemic sclerosis. Demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine 2002; 81:139-53.
12. Foeldvari I, Wierk A. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score. Rheumatology 2006;45:76-8.
13. Quartier P, Bonnet D, Fournet JC et al. Severe cardiac involvement in children with systemic sclerosis and myositis. J Rheumatol 2002;29:1767-73.
14. Foeldvari I, Zhavania M, Birdi N et al. Favourable outcome in 135 children with juvenile systemic sclerosis: Results of a multi-national survey. Rheumatology 2000; 39:556-9.